Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Current Assets: 2022-2024

Historic Current Assets for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $69.2 million.

  • Orchestra BioMed Holdings' Current Assets rose 42.62% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.8 million, marking a year-over-year increase of 42.62%. This contributed to the annual value of $69.2 million for FY2024, which is 22.38% down from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Current Assets is $69.2 million, which was down 22.38% from $89.1 million recorded in FY2023.
  • Orchestra BioMed Holdings' 5-year Current Assets high stood at $89.1 million for FY2023, and its period low was $69.2 million during FY2024.
  • In the last 3 years, Orchestra BioMed Holdings' Current Assets had a median value of $84.7 million in 2022 and averaged $81.0 million.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Current Assets increased by 5.22% in 2023, and later decreased by 22.38% in 2024.
  • Orchestra BioMed Holdings' Current Assets (Yearly) stood at $84.7 million in 2022, then grew by 5.22% to $89.1 million in 2023, then fell by 22.38% to $69.2 million in 2024.